Edgewise Therapeutics Alternatives & Competitors
12 companies similar to Edgewise Therapeutics — On a mission to improve the lives of people facing serious muscle disease.
Companies similar to Edgewise Therapeutics
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Onconova Therapeutics
Onconova is focused on discovering and developing novel products for patients with cancer.
Bionomics Ltd
Developing novel drug candidates to transform the lives of patients with anxiety and stres...
Akebia Therapeutics
We're focused on the development & commercialization of therapeutics for people living wit...
Rival Readout
Competing with Edgewise Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Madrigal Pharmaceuticals
Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease.
AusperBio
Transforming Patient Lives For a Better Tomorrow
AN2 Therapeutics
Developing therapies for rare, chronic, and serious infectious diseases
MapLight Therapeutics, Inc.
Creating breakthrough innovative therapeutics for serious CNS disorders
Pharmacopeia
Innovating to meet critical health challenges with advanced therapeutic discoveries and de...
Vera Therapeutics, Inc.
We are a clinical-stage biotechnology company developing treatments that transform patient...
Agomab
Unlocking Disease Modification in Fibro-Inflammation
Neurotrope Inc.
Developing a new approach to combating Alzheimer's disease and other neurodegenerative dis...
About Edgewise Therapeutics
Edgewise Therapeutics is a biopharmaceutical company established in 2017 with a focus on developing groundbreaking treatments for severe, genetic neuromuscular and cardiac disorders. The company's mission is encapsulated in its slogan, "Creating innovative treatments for severe, genetic neuromuscular and cardiac disord...
Biopharmaceutical, Muscle Disease, Genetic Disorders, Neuromuscular Disorders, Cardiac Conditions, Novel Therapeutics, Muscular Dystrophies, Severe Diseases, Treatment Innovation, NASDAQ, Clinical Research, Drug Development, Medical Breakthroughs
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Edgewise Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Edgewise Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.